Evexias BPC-157 LPT


 BPC-157 LPT contains a pentadecapeptide consisting of 15 amino acids in a chewable tablet with enhanced bioavailability (absorbability) and durability. The synthetic body protection compound (BPC) was first developed by extracting these amino acids from human gastric juices, and BPC-157 LPT has been expertly designed with liposome platform technology (LPT) to deliver BPC to the body more effectively and over longer periods of time than traditional oral applications.


4 in stock (can be backordered)


Additional information

Weight 2.8 oz
Dimensions 1.95 × 1.95 × 3.65 in